189 related articles for article (PubMed ID: 38090560)
21. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.
Li W; Ma G; Wu Q; Deng Y; Liu Y; Wang J
Oncotarget; 2017 Dec; 8(66):110606-110613. PubMed ID: 29299172
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Li LL; Pan LS
Kaohsiung J Med Sci; 2023 Aug; 39(8):842-852. PubMed ID: 37166079
[TBL] [Abstract][Full Text] [Related]
23. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
Front Oncol; 2022; 12():753234. PubMed ID: 35280736
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-Analysis.
Du Y; Wu W; Chen M; Dong Z; Wang F
JAMA Dermatol; 2023 Oct; 159(10):1093-1101. PubMed ID: 37672255
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.
Li W; Tao L; Zhang L; Xiu D
Onco Targets Ther; 2017; 10():3391-3397. PubMed ID: 28744143
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
27. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis.
Sun Q; Sun H; Wu N; Hu Y; Zhang F; Cong X
Front Oncol; 2022; 12():976224. PubMed ID: 36185176
[TBL] [Abstract][Full Text] [Related]
28. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of body composition on survival outcomes in melanoma patients receiving immunotherapy.
Kuang T; Zhang L; Qiu Z; Zhang Y; Wang W
Front Immunol; 2023; 14():1261202. PubMed ID: 38077332
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of tumor mutation burden on survival of gastric cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Ke L; Li S; Huang D
Int Immunopharmacol; 2023 Nov; 124(Pt B):110986. PubMed ID: 37748223
[TBL] [Abstract][Full Text] [Related]
31. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
Front Oncol; 2022; 12():962173. PubMed ID: 36059629
[TBL] [Abstract][Full Text] [Related]
33. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
[TBL] [Abstract][Full Text] [Related]
34. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
35. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
Wang X; Su S; Guo Y
Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
Li J; Cheng Y; Ji Z
Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis.
Wu Q; Hu T; Zheng E; Deng X; Wang Z
Medicine (Baltimore); 2017 Jun; 96(22):e7051. PubMed ID: 28562566
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of
Ling T; Zhang L; Peng R; Yue C; Huang L
Front Immunol; 2022; 13():1014063. PubMed ID: 36466905
[TBL] [Abstract][Full Text] [Related]
39. Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery.
Lieto E; Galizia G; Auricchio A; Cardella F; Mabilia A; Basile N; Del Sorbo G; Castellano P; Romano C; Orditura M; Napolitano V
J Gastrointest Surg; 2017 Nov; 21(11):1764-1774. PubMed ID: 28752404
[TBL] [Abstract][Full Text] [Related]
40. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]